Page last updated: 2024-10-23

azathioprine and Trigeminal Neuralgia

azathioprine has been researched along with Trigeminal Neuralgia in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Trigeminal Neuralgia: A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187)

Research Excerpts

ExcerptRelevanceReference
"This report describes a patient with mixed connective tissue disease (MCTD) and trigeminal neuralgia (TN)."1.33Trigeminal neuralgia as the first manifestation of mixed connective tissue disorder. ( Barland, P; Hojaili, B, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hojaili, B1
Barland, P1

Other Studies

1 other study available for azathioprine and Trigeminal Neuralgia

ArticleYear
Trigeminal neuralgia as the first manifestation of mixed connective tissue disorder.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2006, Volume: 12, Issue:3

    Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Azathioprine; Diagnosis, Differential; Female; Human

2006